This interaction suggests that VDD may specifically potentiate obesity-related OSA mechanisms rather than acting as an independent risk factor, with implications including the role of vitamin D in adipose tissue inflammation, metabolic dysfunction, and insulin resistance. This evidence concerns the gene INS and obstructive sleep apnea syndrome.